Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The SGC is a pre-competitive organisation which, since 2004, has been a world-leader in determining and making available novel Human protein structures. We have taken our protein family-based approach to structural biology and extended it to create a robust chemical biology pipeline to develop high quality, highly characterised chemical probes towards a range of protein families which are then characterised in diseased-tissue assay platforms in a variety of diseases. Capturing and disseminating these workflows, that present diverse data types, scales and modalities, is a significant challenge and has required the development and implementation of novel technologies. I will present examples of the SGC’s solutions ranging from a flexible global LIMS system to tools to assist in the prioritisation of follow-up chemistry from fragment screening datasets.

Type

Conference paper

Publication Date

10/04/2019